Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

"MedGuides" Required Only In Classes Where Patient Info Already Requested

Executive Summary

FDA will initially apply its MedGuide rule only to drug classes where the agency has already asked for patient-directed labeling, the agency said in its final rule "Prescription Drug Product Labeling; Medication Guide Requirements," published Dec. 1.
Advertisement

Related Content

MedGuide-Only REMS Will Be The Exception, Not The Norm, As FDA Relaxes Policy
MedGuide-Only REMS Will Be The Exception, Not The Norm, As FDA Relaxes Policy
MedGuide-Only REMS Will Be The Exception, Not The Norm, As FDA Relaxes Policy
PhRMA Wants MedGuides Developed The Pre-FDAAA Way, Not Through REMS
Advertisement
UsernamePublicRestriction

Register

PS033256

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel